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Ro autoantibodies, including Ro52, have been detected in the sera of patients 
with Sjögren’s syndrome and lupus erythematosus. In patients with lupus, Ro 
auto antibodies have been associated with photosensitivity and with the lupus 
subtype subacute cutaneous lupus erythematosus (Sontheimer et al., 1982). 
Tissue from patients with lupus exhibits Ro52 staining in mononuclear cells, 
especially B cells and those with antiproliferative and cell death–sensitizing 
properties (Espinosa et al., 2006). Ro52 may be a factor in other inflammatory pro-
cesses as well (Higgs et al., 2008), but the ability to detect Ro52 in tissue has been 
limited by the lack of suitable monoclonal antibodies for immunohistochemistry.
In this study, Oke and colleagues (2009) developed a panel of Ro52 monoclonal antibodies to study the 
presence and patterns of Ro52 expression. They initially tested four monoclonal antibodies in both frozen and 
paraffin-embedded tissues. These experiments all yielded similar results, and a single antibody (7.8C7) and 
paraffin-embedded tissues were chosen for subsequent experiments.
Using this monoclonal antibody, Oke et al. studied Ro52 expression in lesional and nonlesional skin from 
patients with lupus and from healthy control subjects, as well as in UVR-induced lesions from patients and in 
UVR-provoked skin from healthy controls. Experiments were confirmed in cultured keratinocytes from the 
nonlesional skin of patients and healthy controls. They demonstrated high expression of Ro52 in the cytoplasm 
of keratinocytes in samples from patients with cutaneous lupus compared with that of controls. Ro52 antigen 
was found to be upregulated by UVR in photoprovocation testing. In vitro confirmatory experiments using 
cultured keratinocytes exposed to UV radiation resulted in increased Ro52 mRNA and protein expression. 
Increased Ro52 expression was also reported in tissues from patients with nonphotoaccentuated inflammatory 
skin disease, suggesting a broad role for Ro52 in cutaneous inflammation.
Through the following questions, we examine this paper in greater detail. For brief answers, please refer to 
http://network.nature.com/group/jidclub.
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QUESTIONS
1. What is Ro52?
2. Describe how Ro52 monoclonal antibodies were developed and chosen for this study.
3. Describe the patterns of Ro52 staining.
4. What are the implications of this study’s findings?
5. What were the limitations of this study?
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